Back to Journals » Clinical Pharmacology: Advances and Applications » Volume 10

The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells

Total article views   HTML views PDF downloads Totals
9,298 Dovepress* 8,443+ 1,245 9,688
PubMed Central* 855 162 1,017
Totals 9,298 1,407 10,705
*Since 9 October 2018
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 1 0 1

View citations on PubMed Central and Google Scholar